Barbara Klencke - 19 Feb 2024 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EFTR	Stock Option (Right to Buy)	Award	$0	+2,000		$0	2,000	19 Feb 2024	Common Stock	2,000	$11.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option will vest in substantially equal monthly installments over 12 months, commencing on February 19, 2024, subject to the Reporting Person's continued service with the Issuer through each vesting date.